Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist Anakinra in Schnitzler syndrome

Acta Dermato-Venereologica

Volumn 92, Issue 4, 2012, Pages 393-394

  Volz, Thomas ^a   Wölbing, Florian ^a   Fischer, Jörg ^a   Braun, Martin ^b   Maggoschitz, Iryna ^a   Schaller, Martin ^a   Berneburg, Mark ^a   Biedermann, Tilo ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Dermatology Practice Dr M Braun   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTHRITIS; BONE PAIN; CASE REPORT; DRUG MEGADOSE; FEMALE; FEVER; HEPATOMEGALY; HUMAN; LETTER; LYMPHADENOPATHY; MUSCULOSKELETAL PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHNITZLER SYNDROME; SPLENOMEGALY; URTICARIA;

BIOPSY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; REMISSION INDUCTION; SCHNITZLER SYNDROME; SKIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863430275     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1307     Document Type: Letter

References (9)

1. Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E. The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) 2001; 80: 37-44.
2. de Koning HD, Bodar EJ, van der Meer JW, Simon A. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 2007; 37: 137-148.
3. Lipsker D, Spehner D, Drillien R, Schmitt P, Cribier B, Heid E, et al. Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol 2000; 142: 954-959.
4. Neven B, Prieur AM, Quartier dit Maire P. Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol 2008; 4: 481-489.
5. Ryan JG, de Koning HD, Beck LA, Booty MG, Kastner DL, Simon A. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allergy Clin Immunol 2008; 121: 260-262.
6. Eiling E, Möller M, Kreiselmaier I, Brasch J, Schwarz T. Schnitzler syndrome: treatment failure to rituximab but response to anakinra. J Am Acad Dermatol 2007; 57: 361-364.
7. Martinez-Taboada VM, Fontalba A, Blanco R, Fernandez-Luna JL. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum 2005; 52: 2226-2227.
8. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004; 50: 607-612.
9. Nakamura Y, Kambe N, Saito M, Nishikomori R, Kim YG, Murakami M, et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med 2009; 206: 1037-1046.